New! Learn more about the all new DeepDyve personalized home page where you can quickly skim your favorite journals all from one place

European Journal of Cancer Supplements Volume 2 Issue 8

2012
- Volume 10
2011
- Volume 9
  - Issue 2 (Oct)
  - Issue 1 (Apr)
2010
- Volume 8
2009
- Volume 7
2008
- Volume 6
2007
- Volume 5
2006
- Volume 4
2005
- Volume 3
2004
- Volume 2
2003
- Volume 1

Bookmark
More Like This s5EOPuML6k Rentable

82 MS-275, a potent orally active inhibitor of histone deacetylases is highly active in experimental tumor models of melanoma and prostate cancer

Hess-Stumpp, H.; Hoffmann, J.; Schott, A.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004
Bookmark
More Like This elsth94BqY Rentable

204 HGS-TR2J, a human, agonistic, TRAIL receptor 2 monoclonal antibody, induces apoptosis, tumor regression and growth inhibition as a single agent in diverse human solid tumor cell lines

Humphreys, R.; Shepard, L.; Poortman, C.; Shields, E.; Johnson, R.; Gillotte, D.; Huang, X.; Albert, V.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004
Bookmark
More Like This CXqSCbnoQI Rentable

661 An androgen-receptor (AR)-negative human prostate cancer xenograft induces mouse-derived osteogenesis

Mathew, P.; Sikes, C.; Multani, A.; Bucana, C.; Prieto, V.G.; Troncoso, P.; Raymond, K.; Logothetis, C.; Navone, N.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004
Bookmark
More Like This TPl00NSxaU Rentable

291 Preclinical evaluation of 177Lu-AMBA, a radiolabelled peptide for systemic radiotherapy and imaging of prostate cancer by targeting gastrin releasing peptide receptors

Nunn, A.D.; Lantry, L.E.; Thomas, R.; Maddalena, M.E.; Fox, J.S.; Arunachalam, T.; Feng, W.; Swenson, R.E.; Tweedle, M.F.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004
Bookmark
More Like This v21T0CFJyT Rentable

171 Unnatural small molecule mimic of VLA-4-binding VCAM-1 epitope inhibits the intravascular adhesion and proliferation of metastatic melanoma cells

Lorea, M.; Aizpea, Z.; Teresa, C.; Silvia, V.; María, V.; Mirari, A.; Ana, A.; Fernando, P.C.; Fernando, V.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004
Bookmark
More Like This cnxjDzY3ya Rentable

497 A bioreductive prodrug of combretstatin A4

Davis, P.D.; Thomson, P.; Naylor, M.A.; Everett, S.A.; Stratford, M.R.L.; Patel, K.B.; Wardman, P.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004
Bookmark
More Like This svwa4cOQIk Rentable

288 A trivalent bispecific fusion protein produced in myeloma cells for improved pretargeting and therapy of CEA-expressing cancers

Rossi, E.; Losman, M.J.; Cardillo, T.M.; Sharkey, R.M.; Karacay, H.; McBride, W.; Horak, I.D.; Goldenberg, D.M.; Chang, C.-H.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004
Bookmark
More Like This R3reB0l0iB Rentable

583 Serum proteomic biomarkers of a natural product in a prospective randomized placebo-controlled clinical trial in patients at risk for lung cancer

Baek, S.; Campos, D.; Izbicka, E.; Jiang, J.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004
Bookmark
More Like This 5LsaSTBARK Rentable

46 Biological testing of the tyrphostin tyrosine kinase inhibitor Adaphostin (NSC 680410) as a vascular endothelial growth factor secretion inhibitor in human and murine tumor cells and tumor-activated bone marrow stromal cells

Egilegor, E.; Mendoza, L.; Gallot, N.; Valcárcel, M.; Solaun, M.; Hollingshead, M.; Sausville, E.; Vidal-Vanaclocha, F.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004
Bookmark
More Like This 1iah90p7G8 Rentable

103 High-throughput screening against intractable targets: the use of target disruption gene signatures for rapid cancer drug discovery

Young, P.E.; Castaneda, J.; Chakiath, M.; Evans, K.; Horrigan, S.K.; Pikul, S.; Shea, M.J.; Soppet, D.R.; Strovel, J.W.; Zong, Q.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

European Journal of Cancer Supplements Volume 2 Issue 8

82 MS-275, a potent orally active inhibitor of histone deacetylases is highly active in experimental tumor models of melanoma and prostate cancer

Hess-Stumpp, H.; Hoffmann, J.; Schott, A.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

204 HGS-TR2J, a human, agonistic, TRAIL receptor 2 monoclonal antibody, induces apoptosis, tumor regression and growth inhibition as a single agent in diverse human solid tumor cell lines

Humphreys, R.; Shepard, L.; Poortman, C.; Shields, E.; Johnson, R.; Gillotte, D.; Huang, X.; Albert, V.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

661 An androgen-receptor (AR)-negative human prostate cancer xenograft induces mouse-derived osteogenesis

Mathew, P.; Sikes, C.; Multani, A.; Bucana, C.; Prieto, V.G.; Troncoso, P.; Raymond, K.; Logothetis, C.; Navone, N.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

291 Preclinical evaluation of 177Lu-AMBA, a radiolabelled peptide for systemic radiotherapy and imaging of prostate cancer by targeting gastrin releasing peptide receptors

Nunn, A.D.; Lantry, L.E.; Thomas, R.; Maddalena, M.E.; Fox, J.S.; Arunachalam, T.; Feng, W.; Swenson, R.E.; Tweedle, M.F.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

171 Unnatural small molecule mimic of VLA-4-binding VCAM-1 epitope inhibits the intravascular adhesion and proliferation of metastatic melanoma cells

Lorea, M.; Aizpea, Z.; Teresa, C.; Silvia, V.; María, V.; Mirari, A.; Ana, A.; Fernando, P.C.; Fernando, V.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

497 A bioreductive prodrug of combretstatin A4

Davis, P.D.; Thomson, P.; Naylor, M.A.; Everett, S.A.; Stratford, M.R.L.; Patel, K.B.; Wardman, P.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

288 A trivalent bispecific fusion protein produced in myeloma cells for improved pretargeting and therapy of CEA-expressing cancers

Rossi, E.; Losman, M.J.; Cardillo, T.M.; Sharkey, R.M.; Karacay, H.; McBride, W.; Horak, I.D.; Goldenberg, D.M.; Chang, C.-H.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

583 Serum proteomic biomarkers of a natural product in a prospective randomized placebo-controlled clinical trial in patients at risk for lung cancer

Baek, S.; Campos, D.; Izbicka, E.; Jiang, J.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

46 Biological testing of the tyrphostin tyrosine kinase inhibitor Adaphostin (NSC 680410) as a vascular endothelial growth factor secretion inhibitor in human and murine tumor cells and tumor-activated bone marrow stromal cells

Egilegor, E.; Mendoza, L.; Gallot, N.; Valcárcel, M.; Solaun, M.; Hollingshead, M.; Sausville, E.; Vidal-Vanaclocha, F.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

103 High-throughput screening against intractable targets: the use of target disruption gene signatures for rapid cancer drug discovery

Young, P.E.; Castaneda, J.; Chakiath, M.; Evans, K.; Horrigan, S.K.; Pikul, S.; Shea, M.J.; Soppet, D.R.; Strovel, J.W.; Zong, Q.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

Advanced Filters:

Specific Data Sources:

European Journal of Cancer Supplements Volume 2 Issue 8

1 - 10 of 673 articles

Hess-Stumpp, H.; Hoffmann, J.; Schott, A.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

Humphreys, R.; Shepard, L.; Poortman, C.; Shields, E.; Johnson, R.; Gillotte, D.; Huang, X.; Albert, V.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

Mathew, P.; Sikes, C.; Multani, A.; Bucana, C.; Prieto, V.G.; Troncoso, P.; Raymond, K.; Logothetis, C.; Navone, N.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

Nunn, A.D.; Lantry, L.E.; Thomas, R.; Maddalena, M.E.; Fox, J.S.; Arunachalam, T.; Feng, W.; Swenson, R.E.; Tweedle, M.F.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

Lorea, M.; Aizpea, Z.; Teresa, C.; Silvia, V.; María, V.; Mirari, A.; Ana, A.; Fernando, P.C.; Fernando, V.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

Davis, P.D.; Thomson, P.; Naylor, M.A.; Everett, S.A.; Stratford, M.R.L.; Patel, K.B.; Wardman, P.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

Rossi, E.; Losman, M.J.; Cardillo, T.M.; Sharkey, R.M.; Karacay, H.; McBride, W.; Horak, I.D.; Goldenberg, D.M.; Chang, C.-H.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

Baek, S.; Campos, D.; Izbicka, E.; Jiang, J.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

Egilegor, E.; Mendoza, L.; Gallot, N.; Valcárcel, M.; Solaun, M.; Hollingshead, M.; Sausville, E.; Vidal-Vanaclocha, F.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004

Young, P.E.; Castaneda, J.; Chakiath, M.; Evans, K.; Horrigan, S.K.; Pikul, S.; Shea, M.J.; Soppet, D.R.; Strovel, J.W.; Zong, Q.

Follow European Journal of Cancer Supplements , Volume 2 (8) Elsevier – Sep 1, 2004